{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:11:26Z","timestamp":1782738686456,"version":"3.54.5"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","license":[{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zhejiang Provincial Science Foundation Committee of China","award":["LQ19H160015"],"award-info":[{"award-number":["LQ19H160015"]}]},{"name":"National Science Foundation Committee (NSFC) of China","award":["81502482"],"award-info":[{"award-number":["81502482"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Gallbladder neuroendocrine carcinoma (GB-NEC) is rare and there are few reports at present. We sought to review the current knowledge of GB-NEC and provide recommendations for clinical management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A systemic literature research was conducted in the websites of Pubmed, Medline, Web of Science, CNKI, Wanfang Data using the keywords including gallbladder combined with neuroendocrine carcinoma or neuroendocrine tumor or neuroendocrine neoplasm. Two reviewers independently screened the articles by reading the title, abstract and full-text.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In computed tomography (CT) and magnetic resonance imaging (MRI) examination, a well-defined margin, gallbladder replacing type with larger hepatic and lymphatic metastases could be helpful for differential diagnosis of GB-NEC and gallbladder adenocarcinoma (GB-ADC). Older age, unmarried status, large tumor size (&gt;5\u200acm), positive margins, and distant Surveillance, Epidemiology and End result (SEER) stage are independently associated with poor survival. Surgical resection remains as the preferred and primary treatment. The potential survival benefit of lymphadenectomy for patients remains controversial. Platinum-based postoperative adjuvant chemotherapy may improve the survival. The efficacy of other treatments including immunotherapy, targeted therapy and somatostatin analogue needs further investigation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Typical imaging features could be helpful for preoperative diagnosis. Age, margin status, tumor size, marital status, histopathologic subtype and SEER stage may be independent predictors for the survival. Remarkable advances regarding the treatment for GB-NEC have been achieved in recent years. Further studies are needed to investigate the survival benefit of lymphadenectomy for patients with GB-NEC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025449","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T04:50:22Z","timestamp":1617857422000},"page":"e25449","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Update in clinical management for gallbladder neuroendocrine carcinoma"],"prefix":"10.1097","volume":"100","author":[{"given":"Hongwu","family":"Chu","sequence":"first","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou"},{"name":"Qingdao University, Qingdao"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Liu","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Dou","sequence":"additional","affiliation":[{"name":"Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,9]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1530\/EC-19-0124","article-title":"Clinicopathological features and survival for gallbladder NEN: a population-based study","volume":"8","author":"Cen","year":"2019","journal-title":"Endocr Connect"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1097\/CCO.0b013e3282f1c595","article-title":"Neuroendocrine tumors of the diffuse neuroendocrine system","volume":"20","author":"Gustafsson","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCG.0b013e3181d7a6d4","article-title":"Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy","volume":"44","author":"Eltawil","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2147\/CMAR.S227501","article-title":"Clinical analysis of 15 cases of gallbladder neuroendocrine carcinoma and comparison with gallbladder adenocarcinoma using a propensity score matching","volume":"12","author":"Yan","year":"2020","journal-title":"Cancer Manag Res"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"e14886","DOI":"10.1097\/MD.0000000000014886","article-title":"Can surgical treatment be justified for neuroendocrine carcinoma of the gallbladder?","volume":"98","author":"You","year":"2019","journal-title":"Medicine"},{"key":"R7-20250504","first-page":"8218","article-title":"Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2006.06.010","article-title":"A close relationship between intestinal metaplasia and Cdx2 expression in human gallbladders with cholelithiasis","volume":"38","author":"Sakamoto","year":"2007","journal-title":"Hum Pathol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1272\/jnms.73.101","article-title":"Combined neuroendocrine cell carcinoma and adenocarcinoma of the gallbladder: report of a case","volume":"73","author":"Shimizu","year":"2006","journal-title":"J Nippon Med Sch"},{"key":"R10-20250504","first-page":"953","article-title":"Carcinoid tumors of the gallbladder with adenocarcinomatous differentiation: a morphologic and immunohistochemical study","volume":"84","author":"Noda","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1385\/EP:11:4:365","article-title":"Gallbladder adenocarcinoma with florid neuroendocrine cell nests and extensive paneth cell metaplasia","volume":"11","author":"Sakaki","year":"2000","journal-title":"Endocr Pathol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jnci\/89.19.1448","article-title":"Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas","volume":"89","author":"Vortmeyer","year":"1997","journal-title":"J Natl Cancer Inst"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J Surg Oncol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1186\/s40001-019-0363-z","article-title":"Neuroendocrine carcinoma of gallbladder: a case series and literature review","volume":"24","author":"Liu","year":"2019","journal-title":"Eur J Med Res"},{"issue":"(Suppl 1)","key":"R16-20250504","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1530\/ERC-11-0013","article-title":"Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms","volume":"18","author":"Kl\u00f6ppel","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"05","DOI":"10.3348\/kjr.2018.0040","article-title":"What is new in the 2017 World Health Organization Classification and 8th American joint committee on cancer staging system for pancreatic neuroendocrine neoplasms?","volume":"20","author":"Choe","year":"2019","journal-title":"Korean J Radiol"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/PAS.0000000000000408","article-title":"The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms","volume":"39","author":"Basturk","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3748\/wjg.v26.i6.686","article-title":"Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: a case report","volume":"26","author":"Jin","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00330-016-4394-3","article-title":"Outcome and CT differentiation of gallbladder neuroendocrine tumours from adenocarcinomas","volume":"27","author":"Kim","year":"2017","journal-title":"Eur Radiol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1007\/s00330-019-06588-9","article-title":"Differential and prognostic MRI features of gallbladder neuroendocrine tumors and adenocarcinomas","volume":"30","author":"Bae","year":"2020","journal-title":"Eur Radiol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s00330-015-3600-z","article-title":"CT differentiation of poorly-differentiated gastric neuroendocrine tumours from well-differentiated neuroendocrine tumours and gastric adenocarcinomas","volume":"25","author":"Kim","year":"2015","journal-title":"Eur Radiol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1148\/rg.276075001","article-title":"Neuroendocrine neoplasms of the gastrointestinal tract: classification, pathologic basis, and imaging features","volume":"27","author":"Chang","year":"2007","journal-title":"Radiographics"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/RCT.0000000000000753","article-title":"Computed tomographic features of primary small cell neuroendocrine tumors of the gallbladder","volume":"42","author":"Faraoun","year":"2018","journal-title":"J Comput Assist Tomogr"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00104-006-1203-6","article-title":"Heterotopic pancreas in the gallbladder. Diagnosis, therapy, and course of a rare developmental anomaly of the pancreas","volume":"78","author":"Neupert","year":"2007","journal-title":"Chirurg"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/153303460700600309","article-title":"Detection of metastases from gastrointestinal neuroendocrine tumors: prospective comparison of 18F-TOCA PET, triplephase CT, and PET\/CT","volume":"6","author":"Seemann","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"R27-20250504","first-page":"247","article-title":"A case of gallbladder neuroendocrine carcinoma diagnosed preoperatively using somatostatin receptor scintigraphy","volume":"19","author":"Kamikihara","year":"2020","journal-title":"Oncol Lett"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s12029-015-9745-9","article-title":"Neuroendocrine carcinoma of gallbladder: a series of 19 cases with review of literature","volume":"46","author":"Kamboj","year":"2015","journal-title":"J Gastrointest Cancer"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/0284186X.2010.492791","article-title":"Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours","volume":"49","author":"Janson","year":"2010","journal-title":"Acta Oncol"},{"key":"R30-20250504","first-page":"517","article-title":"Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases","volume":"22","author":"Soga","year":"2003","journal-title":"J Exp Clin Cancer Res"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"228","DOI":"10.12659\/PJR.893705","article-title":"Neuroendocrine tumor of the gallbladder","volume":"80","author":"Monier","year":"2015","journal-title":"Pol J Radiol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2005.03.038","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","journal-title":"Gastroenterology"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"e8778","DOI":"10.1097\/MD.0000000000008778","article-title":"Cholecystectomy with gallbladder bed cautery might be sufficient for T1bN0M0 neuroendocrine carcinoma of gallbladders: cases report and literature review","volume":"96","author":"Liu","year":"2017","journal-title":"Medicine"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1007\/s00464-017-5952-8","article-title":"Laparoscopic extended cholecystectomy for T3 gallbladder cancer","volume":"32","author":"Kim","year":"2018","journal-title":"Surg Endosc"},{"key":"R35-20250504","first-page":"123","article-title":"Neuroendocrine tumor of the gallbladder","volume":"16","author":"Elahi","year":"2013","journal-title":"Arch Iran Med"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-200105000-00005","article-title":"Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases","volume":"25","author":"Maitra","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/jso.25825","article-title":"Survival benefit of lymphadenectomy for gallbladder cancer based on the therapeutic index: An analysis of the US extrahepatic biliary malignancy consortium","volume":"121","author":"Sahara","year":"2020","journal-title":"J Surg Oncol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB (Oxford)"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2168.2000.01384.x","article-title":"Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma","volume":"87","author":"Kondo","year":"2000","journal-title":"Br J Surg"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40792-016-0200-3","article-title":"Gallbladder small cell carcinoma: a case report and literature review","volume":"2","author":"Adachi","year":"2016","journal-title":"Surg Case Rep"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12029-018-0070-y","article-title":"Neuroendocrine carcinoma of gallbladder: a step beyond palliative therapy, experience of 25 cases","volume":"50","author":"Kanetkar","year":"2019","journal-title":"J Gastrointest Cancer"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/MPA.0000000000001480","article-title":"Durable response to carboplatin, etoposide, nivolumab, and ipilimumab in metastatic high-grade neuroendocrine carcinoma of the gallbladder","volume":"49","author":"Chorath","year":"2020","journal-title":"Pancreas"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s11523-017-0506-5","article-title":"Predictive markers of response to everolimus and sunitinib in neuroendocrine tumors","volume":"12","author":"Martins","year":"2017","journal-title":"Target Oncol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000338371","article-title":"Angiogenesis in neuroendocrine tumors: therapeutic applications","volume":"97","author":"Scoazec","year":"2013","journal-title":"Neuroendocrinology"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00280-017-3367-9","article-title":"Sunitinib is effective and tolerable in Chinese patients with advanced pancreatic neuroendocrine tumors: a multicenter retrospective study in China","volume":"80","author":"Wang","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00280-017-3482-7","article-title":"Dose and schedule modification are required for long-term continuation of sunitinib in Japanese patients with advanced pancreatic neuroendocrine tumors","volume":"81","author":"Lee","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1200\/JCO.2008.16.7858","article-title":"Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12020-014-0380-1","article-title":"PI3K\/Akt\/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy","volume":"48","author":"Manfredi","year":"2015","journal-title":"Endocrine"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"44841","DOI":"10.18632\/oncotarget.8601","article-title":"How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies","volume":"7","author":"Pusceddu","year":"2016","journal-title":"Oncotarget"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/030089161209800319","article-title":"Sunitinib and everolimus in pancreatic neuroendocrine tumors","volume":"98","author":"Procopio","year":"2012","journal-title":"Tumori"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1758834016683905","article-title":"Everolimus treatment for neuroendocrine tumors: latest results and clinical potential","volume":"9","author":"Pusceddu","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1556\/OH.2014.30048","article-title":"Efficacy of somatostatin analogues in the treatment of neuroendocrine tumours based on the results of recent clinical trials","volume":"155","author":"Igaz","year":"2014","journal-title":"Orvosi Hetilap"},{"key":"R53-20250504","doi-asserted-by":"crossref","first-page":"v223","DOI":"10.1093\/annonc\/mdq192","article-title":"Neuroendocrine gastroenteropancreatic tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Oberg","year":"2010","journal-title":"Ann Oncol"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<54::AID-JSO10>3.0.CO;2-W","article-title":"Small cell carcinoma of the gallbladder","volume":"70","author":"Moskal","year":"1999","journal-title":"J Surg Oncol"},{"key":"R55-20250504","first-page":"1064","article-title":"Neuroendocrine tumors of the gallbladder: twelve cases in a single institution","volume":"57","author":"Lee","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3748\/wjg.v21.i1.269","article-title":"Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder","volume":"21","author":"Yun","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R57-20250504","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1245\/s10434-019-07440-6","article-title":"Primary gallbladder neuroendocrine tumors: insights into a rare histology using a large national database","volume":"26","author":"Ayabe","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:19:40Z","timestamp":1746339580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,9]]},"references-count":57,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025449","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,9]]},"assertion":[{"value":"2020-10-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}